MicroRNA-572 improves early post-operative cognitive dysfunction by down-regulating neural cell adhesion molecule 1

Area of Science:

• Neuroscience
• Molecular Biology
• Geriatrics

Background:

• Post-operative cognitive dysfunction (POCD) is a frequent complication in elderly patients.
• The precise mechanisms underlying POCD remain largely unknown.
• MicroRNAs (miRNAs) are implicated in nervous system diseases and may play a role in POCD.

Purpose of the Study:

• To investigate the role of circulating miRNAs in the pathogenesis of POCD.
• To identify potential biomarkers for early POCD diagnosis.
• To explore the therapeutic potential of targeting specific miRNAs in POCD.

Main Methods:

• miRNA microarray technology was employed to analyze circulating miRNA expression profiles in POCD patients.
• In vivo rat models of POCD were established to validate findings.
• Expression levels of miR-572 and its target gene NCAM1 were assessed in hippocampal neurons.
• Intervention studies were performed to evaluate the effect of modulating miR-572 on cognitive function.

Main Results:

• A distinct circulating miRNA expression profile was identified in POCD patients.
• miR-572 showed the most significant decrease among altered miRNAs and was validated in a rat POCD model.
• miR-572 was found to regulate NCAM1 expression in hippocampal neurons.
• Interfering with miR-572 expression promoted the restoration of cognitive function in vivo.
• Clinical correlation analysis revealed an association between miR-572 expression levels and POCD incidence.

Conclusions:

• miR-572 is critically involved in both the development and recovery phases of POCD.
• Modulating miR-572 offers a potential therapeutic strategy for POCD.
• miR-572 may serve as a valuable biomarker for the early diagnosis of POCD.